Literature DB >> 14677081

Stress responsive neurohormones in depression and anxiety.

A Ströhle1, F Holsboer.   

Abstract

Clinical and preclinical studies have gathered substantial evidence that stress response alterations play a major role in the development of major depression, panic disorder and posttraumatic stress disorder. The stress response, the hypothalamic pituitary adrenocortical (HPA) system and its modulation by CRH, corticosteroids and their receptors as well as the role of natriuretic peptides and neuroactive steroids are described. Examplarily, we review the role of the HPA system in major depression, panic disorder and posttraumatic stress disorder as well as its possible relevance for treatment. Impaired glucocorticoid receptor function in major depression is associated with an excessive release of neurohormones, like CRH to which a number of signs and symptoms characteristic of depression can be ascribed. In panic disorder, a role of central CRH in panic attacks has been suggested. Atrial natriuretic peptide (ANP) is causally involved in sodium lactate-induced panic attacks. Furthermore, preclinical and clinical data on its anxiolytic activity suggest that non-peptidergic ANP receptor ligands may be of potential use in the treatment of anxiety disorders. Recent data further suggest a role of 3alpha-reduced neuroactive steroids in major depression, panic attacks and panic disorder. Posttraumatic stress disorder is characterized by a peripheral hyporesponsive HPA-system and elevated CRH concentrations in CSF. This dissociation is probably related to an increased risk for this disorder. Antidepressants are effective both in depression and anxiety disorders and have major effects on the HPA-system, especially on glucocorticoid and mineralocorticoid receptors. Normalization of HPA-system abnormalities is a strong predictor of the clinical course, at least in major depression and panic disorder. CRH-R1 or glucorticoid receptor antagonists and ANP receptor agonists are currently being studied and may provide future treatment options more closely related to the pathophysiology of the disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14677081     DOI: 10.1055/s-2003-45132

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  67 in total

1.  Heightening of the stress response during the first weeks after a mild traumatic brain injury.

Authors:  G S Griesbach; D A Hovda; D L Tio; A N Taylor
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 2.  Psychological stress and aging: role of glucocorticoids (GCs).

Authors:  K M Mehedi Hasan; Md Shaifur Rahman; K M T Arif; Mahbub E Sobhani
Journal:  Age (Dordr)       Date:  2011-10-05

3.  Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression.

Authors:  Ali A Weinstein; Patricia A Deuster; Jennifer L Francis; Robert W Bonsall; Russell P Tracy; Willem J Kop
Journal:  Biol Psychol       Date:  2010-01-29       Impact factor: 3.251

4.  Central serotonin transporter levels are associated with stress hormone response and anxiety.

Authors:  Matthias Reimold; Astrid Knobel; Michael A Rapp; Anil Batra; Klaus Wiedemann; Andreas Ströhle; Anke Zimmer; Peter Schönknecht; Michael N Smolka; Daniel R Weinberger; David Goldman; Hans-Jürgen Machulla; Roland Bares; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2010-06-29       Impact factor: 4.530

Review 5.  The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans.

Authors:  George A Kenna; Robert M Swift; Thomas Hillemacher; Lorenzo Leggio
Journal:  Neuropsychol Rev       Date:  2012-07-07       Impact factor: 7.444

6.  Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling.

Authors:  Casey E O'Neill; Ryan J Newsom; Jacob Stafford; Talia Scott; Solana Archuleta; Sophia C Levis; Robert L Spencer; Serge Campeau; Ryan K Bachtell
Journal:  Psychoneuroendocrinology       Date:  2016-02-01       Impact factor: 4.905

Review 7.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

Review 8.  Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications.

Authors:  Daniela Jezova
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

9.  Fucoidan prevents depression-like behavior in rats exposed to repeated restraint stress.

Authors:  Bombi Lee; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  J Nat Med       Date:  2012-10-23       Impact factor: 2.343

10.  Asparagus racemosus attenuates anxiety-like behavior in experimental animal models.

Authors:  Debapriya Garabadu; Sairam Krishnamurthy
Journal:  Cell Mol Neurobiol       Date:  2014-02-21       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.